DONG IL GWON

Prof. Dr. DONG IL GWON

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in Radiology
Verified
Journal Article
Closed access
DGDONG IL GWON
DONG IL GWON
GKGi-Young Ko
Gi-Young Ko
HYHyun-Ki Yoon
Hyun-Ki Yoon
KSKyu-Bo Sung
Kyu-Bo Sung
Jin Hyoung KimJin Hyoung Kim
Jin Hyoung Kim
HSHo-Young Song
Ho-Young Song
To evaluate technical safety, clinical safety, and effectiveness of vascular plug-assisted retrograde transvenous obliteration (RTO) for treatment of gastric varices (GV) and hepatic encephalopathy (HE). This retrospective study was approved by the institutional review board; written informed consent was waived. From April 2009 to December 2011, 20 patients (13, GV; seven, HE) who had undergone vascular plug-assisted RTO were retrospectively evaluated. After retrograde transvenous placement of a vascular plug in the left adrenal vein or gastrorenal shunt, subsequent gelatin-sponge embolization of both gastrorenal shunt and GV was performed. Follow-up computed tomography (CT) and upper gastrointestinal tract endoscopy were performed; clinical and laboratory data were collected to evaluate primary (technical success, complications, clinical success) and secondary (change of liver function by using the Child-Pugh score, worsening of esophageal varices) end points. Laboratory data before and after vascular plug-assisted RTO were compared (paired-sample t test). Placement of the vascular plug and subsequent gelatin-sponge embolization were technically successful in all 20 patients, with no procedure-related complications. Follow-up CT within 1 week after vascular plug-assisted RTO showed complete thrombosis of GV and gastrorenal shunts in all patients. Clinical symptoms of HE completely resolved in all seven patients with HE; mean serum NH3 level of 127.4 μmol/L ± 58 (standard deviation) before vascular plug-assisted RTO decreased significantly to 28.1 μmol/L ± 9.8 within 1 week after vascular plug-assisted RTO (P = .002). Eighteen patients who underwent follow-up longer than 2 months showed complete obliteration of GV and gastrorenal shunts at CT and endoscopy. There were no cases of variceal bleeding or HE during mean follow-up of 422 days. Improvement in Child-Pugh score was observed in 12 of 18 (67%) patients 1 month after vascular plug-assisted RTO. Worsening of esophageal varices was observed in four (22%) patients at mean follow-up of 9.4 months. Vascular plug-assisted RTO is technically simple and safe and seems to be clinically effective for treatment of GV and HE.

1 November 2015 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
DGDONG IL GWON
DONG IL GWON
YKYoung Hwan Kim
Young Hwan Kim
GKGi-Young Ko
Gi-Young Ko
JKJong Woo Kim
Jong Woo Kim
HKHeung Kyu Ko
Heung Kyu Ko
KSKyu-Bo Sung
Kyu-Bo Sung

1 March 2013 in Radiology
Verified
Journal Article
Closed access
DGDONG IL GWON
DONG IL GWON
GKGi-Young Ko
Gi-Young Ko
JKJin Hyoung Kim
Jin Hyoung Kim
JSJi Hoon Shin
Ji Hoon Shin
HYHyun-Ki Yoon
Hyun-Ki Yoon
KSKyu-Bo Sung
Kyu-Bo Sung
To evaluate outcomes of expanded polytetrafluoroethylene (ePTFE)-covered stents and compare them with outcomes of uncovered stents in patients with malignant superior vena cava (SVC) syndrome. This study was approved by the institutional review board and written informed consent was obtained. Thirty-seven consecutive patients (33 men, four women; mean age, 60.3 years; range, 35-81 years) who underwent ePTFE-covered stent placement for SVC syndrome were enrolled in a prospective study between January 2009 and September 2011. Their data were compared with retrospective data of 36 consecutive patients (31 men, five women; mean age, 62.3 years; range, 41-81 years) who underwent uncovered stent placement for SVC syndrome between January 2005 and December 2008. The causes of malignant SVC syndrome were squamous cell carcinoma (n = 27), adenocarcinoma (n = 25), small cell carcinoma (n = 15), thymic carcinoma (n = 3), invasive thymoma (n = 2), and breast cancer (n = 1). Stent patency and patient survival rates were calculated by using the Kaplan-Meier method, and groups were compared with the log-rank test. Stent placement was technically successful in all patients. Complications did not occur in either group. Kaplan-Meier analysis revealed that covered stents had higher cumulative patency (97%, 94%, 94%, and 94% at 1, 3, 6, and 12 months, respectively) than uncovered stents (97%, 79%, 67%, and 48% at 1, 3, 6, and 12 months, respectively; P = .038). Clinical success rates did not significantly differ (P = .674), nor did patient survival (P = .549). Median survival in the covered stent group was 141 days (95% confidence interval: 81, 201 days) and 100 days in the uncovered stent group (95% confidence interval: 60, 140 days). Endovascular placement of ePTFE-covered stents appeared to be a safe and effective method to treat patients with malignant SVC syndrome and seemed to be superior to uncovered stents in terms of stent patency.

1 May 2011 in American Journal of Roentgenology
Verified
Journal Article
Closed access
DGDONG IL GWON
DONG IL GWON
GKGi-Young Ko
Gi-Young Ko
KSKyu-Bo Sung
Kyu-Bo Sung
JSJi Hoon Shin
Ji Hoon Shin
JKJin Hyoung Kim
Jin Hyoung Kim
HYHyun-Ki Yoon
Hyun-Ki Yoon
OBJECTIVE. The objective of our study was to analyze the technical and clinical outcomes of endovascular treatment of patients with extrahepatic artery hemorrhage after pancreatobiliary surgery.MATERIALS AND METHODS. From January 2000 to September 2009, 27 patients who had undergone pancreaticobiliary surgery had an extrahepatic artery hemorrhage with or without a pseudoaneurysm were enrolled in this retrospective study. All patients underwent diagnostic angiography and endovascular treatment—either transcatheter arterial embolization (TAE) (n = 20) or stent-graft placement (n = 7).RESULTS. Bleeding sites were located in the gastroduodenal artery stump (n = 14), proper hepatic artery (n = 10), and common hepatic artery (n = 3). In the TAE group, the initial technical and clinical success rates were 100% and 90%, respectively. Two patients died of hepatic failure and multiorgan failure within 7 days after TAE. Hepatic ischemia and infarction were observed in six (33.3%, 6/18) and eight (44.4%, 8/18) patien...

7 November 2017 in European Radiology
Verified
Journal Article
Closed access
PDF file
SNSeung Yeon Noh
Seung Yeon Noh
DGDONG IL GWON
DONG IL GWON
GKGi-Young Ko
Gi-Young Ko
HYHyun-Ki Yoon
Hyun-Ki Yoon
KSKyu-Bo Sung
Kyu-Bo Sung